Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,987 | -10,626 | -24,208 | -29,146 | -161 |
| Depreciation Amortization | 1,197 | 326 | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | -579 | -1,234 | N/A | N/A | N/A |
| Other Working Capital | -851 | -947 | 5,482 | -1,304 | 185 |
| Other Operating Activity | 717 | 1,702 | 839 | 22,207 | -1,272 |
| Operating Cash Flow | $-7,503 | $-10,780 | $-17,887 | $-8,242 | $-1,247 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 5 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $5 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,606 | 7,534 | 14,380 | 1,100 |
| Debt Repayment | -485 | -1,000 | -1,408 | -468 | N/A |
| Common Stock Issued | 12,207 | 9,050 | 3,783 | 6,889 | N/A |
| Other Financing Activity | -1,841 | -900 | -1,143 | -489 | 0 |
| Financing Cash Flow | $9,881 | $8,756 | $8,766 | $20,313 | $1,100 |
| Beginning Cash Position | 1,124 | 3,148 | 12,265 | 194 | 342 |
| End Cash Position | 3,502 | 1,124 | 3,148 | 12,265 | 194 |
| Net Cash Flow | $2,379 | $-2,024 | $-9,117 | $12,071 | $-147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,503 | -10,780 | -17,887 | -8,242 | -1,247 |
| Free Cash Flow | -7,503 | -10,780 | -17,887 | -8,242 | -1,247 |